Coexpression of LAG-3 and PD-1 on tumor-infiltrating lymphocytes results in a cooperative immunosuppressive effect133that could be upheld to some degree even after ICI monotherapy targeting PD-1/PD-L1 resulting in resistance. Here, LAG3 is linked to neoplasm.